Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (71-80 of 414) with videos related to

Pageof 42
Sort By:
Vascular Medicine (London, England)|January 1, 1996
The PACK trial: morbidity and mortality effects of ketanserin. Prevention of Atherosclerotic ComplicationsM Verstraete
Acta Cardiologica|January 1, 1989
Evolving European consensus on critical limb ischaemiaM Verstraete
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Value and limitation of meta-analysisM Verstraete
Agents and Actions. Supplements|January 1, 1984
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteriesM Verstraete
Haemostasis|January 1, 1982
A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte LectureM Verstraete
Annales De Medecine Interne|January 1, 1986
[Prevention of deep venous thrombosis and pulmonary embolism in general surgery]M Verstraete
Drugs|October 1, 1990
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparinsM Verstraete
Recenti Progressi in Medicina|April 1, 1990
[Thrombolytic therapy in acute myocardial infarct]M Verstraete
Thrombosis and Haemostasis|July 1, 1995
The fibrinolytic system: from Petri dishes to genetic engineeringM Verstraete
European Heart Journal|November 1, 1995
New developments in antiplatelet and antithrombotic therapyM Verstraete
Pageof 42

Showing results (71-80 of 414) with videos related to

Sort By:
Pageof 42
Vascular Medicine (London, England)|January 1, 1996
The PACK trial: morbidity and mortality effects of ketanserin. Prevention of Atherosclerotic ComplicationsM Verstraete
Acta Cardiologica|January 1, 1989
Evolving European consensus on critical limb ischaemiaM Verstraete
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Value and limitation of meta-analysisM Verstraete
Agents and Actions. Supplements|January 1, 1984
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteriesM Verstraete
Haemostasis|January 1, 1982
A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte LectureM Verstraete
Annales De Medecine Interne|January 1, 1986
[Prevention of deep venous thrombosis and pulmonary embolism in general surgery]M Verstraete
Drugs|October 1, 1990
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparinsM Verstraete
Recenti Progressi in Medicina|April 1, 1990
[Thrombolytic therapy in acute myocardial infarct]M Verstraete
Thrombosis and Haemostasis|July 1, 1995
The fibrinolytic system: from Petri dishes to genetic engineeringM Verstraete
European Heart Journal|November 1, 1995
New developments in antiplatelet and antithrombotic therapyM Verstraete
Pageof 42